Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-29 4:35 pm Unchanged | 2024-05-24 | 13D | PASSAGE BIO INC PASG | Versant Venture Capital VI, L.P. | 201,321 6.500% | 0 (Unchanged) | Filing History |
| 2024-05-13 4:54 pm Unchanged | 2024-03-19 | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI, L.P. | 162,973 9.500% | 0 (Unchanged) | Filing History |
| 2024-03-25 4:43 pm Sale | 2024-03-21 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 2,101,199 8.200% | -1 (-0.00%) | Filing History |
| 2024-02-08 5:44 pm Unchanged | 2023-11-02 | 13D | ALIGOS THERAPEUTICS INC ALGS | Versant Venture Capital VI, L.P. | 58,317 1.900% | 0 (Unchanged) | Filing History |
| 2024-02-08 5:41 pm Unchanged | 2023-11-08 | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI, L.P. | 162,973 11.000% | 0 (Unchanged) | Filing History |
| 2024-02-08 5:35 pm Unchanged | 2023-12-31 | 13G | CENTURY THERAPEUTICS INC IPSC | Versant Venture Capital VI, L.P. | 11,452,014 19.100% | 0 (Unchanged) | Filing History |
| 2023-11-17 4:38 pm Unchanged | 2023-11-14 | 13D | GRAPHITE BIO INC GRPH | Versant Venture Capital VI, L.P. | 2,101,200 25.400% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:28 pm Unchanged | 2023-08-10 | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI, L.P. | 162,973 15.900% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:27 pm Unchanged | 2023-08-07 | 13D | PASSAGE BIO INC PASG | Versant Venture Capital VI, L.P. | 201,321 7.300% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:26 pm Unchanged | 2023-08-10 | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | Versant Venture Capital VI, L.P. | 6,799,115 13.700% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:24 pm Unchanged | 2023-08-11 | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | Versant Venture Capital VI, L.P. | 4,328,883 8.400% | 0 (Unchanged) | Filing History |
| 2023-02-09 4:19 pm Sale | 2022-12-31 | 13G | CENTURY THERAPEUTICS INC IPSC | Versant Venture Capital VI, L.P. | 11,452,014 19.400% | -914,800 (-7.40%) | Filing History |
| 2023-01-13 4:09 pm Sale | 2023-01-03 | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI, L.P. | 0 0.000% | -2,236,888 (Position Closed) | Filing History |
| 2022-05-09 5:26 pm Purchase | 2022-04-29 | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI, L.P. | 162,973 20.500% | 72,321 (+79.78%) | Filing History |
| 2022-02-10 8:39 pm Purchase | 2021-12-31 | 13G | CENTURY THERAPEUTICS INC IPSC | Versant Venture Capital VI, L.P. | 12,366,814 22.600% | 12,366,814 (New Position) | Filing History |
| 2022-02-10 7:41 pm Purchase | 2021-12-31 | 13G | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI, L.P. | 90,652 17.100% | 90,652 (New Position) | Filing History |
| 2022-01-13 4:34 pm Unchanged | 2022-01-05 | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.500% | 0 (Unchanged) | Filing History |
| 2021-10-27 4:32 pm Unchanged | 2021-10-18 | 13D | OYSTER PT PHARMA INC OYST | Versant Venture Capital VI, L.P. | 2,236,888 8.600% | 0 (Unchanged) | Filing History |
| 2021-07-09 4:43 pm Purchase | 2021-06-29 | 13D | GRAPHITE BIO INC GRPH | Versant Venture Capital VI, L.P. | 2,101,200 26.300% | 2,101,200 (New Position) | Filing History |
| 2021-07-08 4:31 pm Purchase | 2021-06-28 | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | Versant Venture Capital VI, L.P. | 6,799,115 15.300% | 6,799,115 (New Position) | Filing History |